世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

B型肝炎ワクチン接種の世界市場に関する洞察、2028年までの予測


Global Hepatitis B Vaccination Market Insights, Forecast to 2028

B型肝炎ワクチンは、B型肝炎を予防するワクチンで、生後24時間以内に1回目の接種を行い、その後2回または3回の接種を行うことが推奨されています。HIV/AIDSなど免疫機能が低下している方、早産で生まれた方などが... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年6月17日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

B型肝炎ワクチンは、B型肝炎を予防するワクチンで、生後24時間以内に1回目の接種を行い、その後2回または3回の接種を行うことが推奨されています。HIV/AIDSなど免疫機能が低下している方、早産で生まれた方などが対象となります。また、医療従事者への接種も推奨されています。健康な人が定期的に予防接種を受けると、95%以上の人が予防されます。

市場の分析と洞察B型肝炎ワクチン接種の世界市場
COVID-19の大流行により、世界のB型肝炎ワクチン市場規模は2022年に百万米ドル相当と推定され、2028年には予測期間2022-2028年にCAGR%で、百万米ドルの再調整サイズとなると予測されています。この健康危機による経済変化を十分に考慮し、2021年にB型肝炎ワクチン世界市場の%を占めた酵母由来は、2022年から2028年まで修正された%のCAGRで成長し、2028年までに百万米ドルを値すると予測されます。一方、小児部門は、この予測期間を通して%CAGRに変更されています。

中国B型肝炎ワクチン市場規模は2021年に百万米ドル、米国と欧州B型肝炎ワクチン市場規模はそれぞれ百万米ドル、百万米ドルとなっています。米国の割合は2021年に%、中国と欧州はそれぞれ%、%であり、中国の割合は2028年に%に達すると予測され、分析期間2022-2028年を通じてCAGRは%であると追跡しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。欧州のB型肝炎ワクチンの展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間2022年から2028年にかけてCAGR %を推移しています。
B型肝炎ワクチン接種の世界の主要メーカーは、GSK、NCPC、Merck、Bio Kangtai、Dynavax、Hissen、KM Biologics、LG Life Sciences、Serum Institute.などです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

世界のB型肝炎ワクチン接種の範囲とセグメント
B型肝炎ワクチン接種市場は、タイプ別と用途別に区分されます。B型肝炎ワクチン接種の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができます。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上高、収益、予測に焦点を当てています。

タイプ別セグメント
酵母由来
CHO由来

用途別セグメント
小児
アダルト

会社別
GSK
NCPC
メルク
バイオカンタイ
ダイナバックス
ヒッセン
KMバイオロジックス
LGライフサイエンス
血清研究所

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE


ページTOPに戻る


目次

1 Study Coverage
1.1 Hepatitis B Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Market by Application
1.3.1 Global Hepatitis B Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Vaccination Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis B Vaccination Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis B Vaccination Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis B Vaccination Sales by Region
2.4.1 Global Hepatitis B Vaccination Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis B Vaccination by Region (2023-2028)
2.5 Global Hepatitis B Vaccination Revenue by Region
2.5.1 Global Hepatitis B Vaccination Revenue by Region (2017-2022)
2.5.2 Global Hepatitis B Vaccination Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis B Vaccination Sales by Manufacturers
3.1.1 Global Top Hepatitis B Vaccination Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccination in 2021
3.2 Global Hepatitis B Vaccination Revenue by Manufacturers
3.2.1 Global Hepatitis B Vaccination Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis B Vaccination Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccination Revenue in 2021
3.3 Global Hepatitis B Vaccination Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis B Vaccination Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis B Vaccination Sales by Type
4.1.1 Global Hepatitis B Vaccination Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis B Vaccination Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis B Vaccination Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis B Vaccination Revenue by Type
4.2.1 Global Hepatitis B Vaccination Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis B Vaccination Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis B Vaccination Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis B Vaccination Price by Type
4.3.1 Global Hepatitis B Vaccination Price by Type (2017-2022)
4.3.2 Global Hepatitis B Vaccination Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis B Vaccination Sales by Application
5.1.1 Global Hepatitis B Vaccination Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis B Vaccination Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis B Vaccination Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis B Vaccination Revenue by Application
5.2.1 Global Hepatitis B Vaccination Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis B Vaccination Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis B Vaccination Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis B Vaccination Price by Application
5.3.1 Global Hepatitis B Vaccination Price by Application (2017-2022)
5.3.2 Global Hepatitis B Vaccination Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis B Vaccination Market Size by Type
6.1.1 North America Hepatitis B Vaccination Sales by Type (2017-2028)
6.1.2 North America Hepatitis B Vaccination Revenue by Type (2017-2028)
6.2 North America Hepatitis B Vaccination Market Size by Application
6.2.1 North America Hepatitis B Vaccination Sales by Application (2017-2028)
6.2.2 North America Hepatitis B Vaccination Revenue by Application (2017-2028)
6.3 North America Hepatitis B Vaccination Market Size by Country
6.3.1 North America Hepatitis B Vaccination Sales by Country (2017-2028)
6.3.2 North America Hepatitis B Vaccination Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis B Vaccination Market Size by Type
7.1.1 Europe Hepatitis B Vaccination Sales by Type (2017-2028)
7.1.2 Europe Hepatitis B Vaccination Revenue by Type (2017-2028)
7.2 Europe Hepatitis B Vaccination Market Size by Application
7.2.1 Europe Hepatitis B Vaccination Sales by Application (2017-2028)
7.2.2 Europe Hepatitis B Vaccination Revenue by Application (2017-2028)
7.3 Europe Hepatitis B Vaccination Market Size by Country
7.3.1 Europe Hepatitis B Vaccination Sales by Country (2017-2028)
7.3.2 Europe Hepatitis B Vaccination Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccination Market Size by Type
8.1.1 Asia Pacific Hepatitis B Vaccination Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis B Vaccination Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis B Vaccination Market Size by Application
8.2.1 Asia Pacific Hepatitis B Vaccination Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis B Vaccination Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis B Vaccination Market Size by Region
8.3.1 Asia Pacific Hepatitis B Vaccination Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis B Vaccination Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Hepatitis B Vaccination Market Size by Type
9.1.1 Latin America Hepatitis B Vaccination Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis B Vaccination Revenue by Type (2017-2028)
9.2 Latin America Hepatitis B Vaccination Market Size by Application
9.2.1 Latin America Hepatitis B Vaccination Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis B Vaccination Revenue by Application (2017-2028)
9.3 Latin America Hepatitis B Vaccination Market Size by Country
9.3.1 Latin America Hepatitis B Vaccination Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis B Vaccination Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Vaccination Market Size by Type
10.1.1 Middle East and Africa Hepatitis B Vaccination Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis B Vaccination Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis B Vaccination Market Size by Application
10.2.1 Middle East and Africa Hepatitis B Vaccination Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis B Vaccination Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis B Vaccination Market Size by Country
10.3.1 Middle East and Africa Hepatitis B Vaccination Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis B Vaccination Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 NCPC
11.2.1 NCPC Corporation Information
11.2.2 NCPC Overview
11.2.3 NCPC Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 NCPC Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NCPC Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Bio Kangtai
11.4.1 Bio Kangtai Corporation Information
11.4.2 Bio Kangtai Overview
11.4.3 Bio Kangtai Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bio Kangtai Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio Kangtai Recent Developments
11.5 Dynavax
11.5.1 Dynavax Corporation Information
11.5.2 Dynavax Overview
11.5.3 Dynavax Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dynavax Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dynavax Recent Developments
11.6 Hissen
11.6.1 Hissen Corporation Information
11.6.2 Hissen Overview
11.6.3 Hissen Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hissen Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hissen Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 KM Biologics Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 KM Biologics Recent Developments
11.8 LG Life Sciences
11.8.1 LG Life Sciences Corporation Information
11.8.2 LG Life Sciences Overview
11.8.3 LG Life Sciences Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 LG Life Sciences Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 LG Life Sciences Recent Developments
11.9 Serum Institute
11.9.1 Serum Institute Corporation Information
11.9.2 Serum Institute Overview
11.9.3 Serum Institute Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Serum Institute Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Serum Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis B Vaccination Industry Chain Analysis
12.2 Hepatitis B Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis B Vaccination Production Mode & Process
12.4 Hepatitis B Vaccination Sales and Marketing
12.4.1 Hepatitis B Vaccination Sales Channels
12.4.2 Hepatitis B Vaccination Distributors
12.5 Hepatitis B Vaccination Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis B Vaccination Industry Trends
13.2 Hepatitis B Vaccination Market Drivers
13.3 Hepatitis B Vaccination Market Challenges
13.4 Hepatitis B Vaccination Market Restraints
14 Key Findings in The Global Hepatitis B Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.

Market Analysis and Insights: Global Hepatitis B Vaccination Market
Due to the COVID-19 pandemic, the global Hepatitis B Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Yeast Derived accounting for % of the Hepatitis B Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Children segment is altered to an % CAGR throughout this forecast period.

China Hepatitis B Vaccination market size is valued at US$ million in 2021, while the US and Europe Hepatitis B Vaccination are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hepatitis B Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Hepatitis B Vaccination include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences and Serum Institute. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Hepatitis B Vaccination Scope and Segment
Hepatitis B Vaccination market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Hepatitis B Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Yeast Derived
CHO Derived

Segment by Application
Children
Adult

By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Hepatitis B Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Market by Application
1.3.1 Global Hepatitis B Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Vaccination Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis B Vaccination Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis B Vaccination Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis B Vaccination Sales by Region
2.4.1 Global Hepatitis B Vaccination Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis B Vaccination by Region (2023-2028)
2.5 Global Hepatitis B Vaccination Revenue by Region
2.5.1 Global Hepatitis B Vaccination Revenue by Region (2017-2022)
2.5.2 Global Hepatitis B Vaccination Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis B Vaccination Sales by Manufacturers
3.1.1 Global Top Hepatitis B Vaccination Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccination in 2021
3.2 Global Hepatitis B Vaccination Revenue by Manufacturers
3.2.1 Global Hepatitis B Vaccination Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis B Vaccination Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccination Revenue in 2021
3.3 Global Hepatitis B Vaccination Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis B Vaccination Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis B Vaccination Sales by Type
4.1.1 Global Hepatitis B Vaccination Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis B Vaccination Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis B Vaccination Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis B Vaccination Revenue by Type
4.2.1 Global Hepatitis B Vaccination Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis B Vaccination Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis B Vaccination Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis B Vaccination Price by Type
4.3.1 Global Hepatitis B Vaccination Price by Type (2017-2022)
4.3.2 Global Hepatitis B Vaccination Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis B Vaccination Sales by Application
5.1.1 Global Hepatitis B Vaccination Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis B Vaccination Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis B Vaccination Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis B Vaccination Revenue by Application
5.2.1 Global Hepatitis B Vaccination Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis B Vaccination Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis B Vaccination Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis B Vaccination Price by Application
5.3.1 Global Hepatitis B Vaccination Price by Application (2017-2022)
5.3.2 Global Hepatitis B Vaccination Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis B Vaccination Market Size by Type
6.1.1 North America Hepatitis B Vaccination Sales by Type (2017-2028)
6.1.2 North America Hepatitis B Vaccination Revenue by Type (2017-2028)
6.2 North America Hepatitis B Vaccination Market Size by Application
6.2.1 North America Hepatitis B Vaccination Sales by Application (2017-2028)
6.2.2 North America Hepatitis B Vaccination Revenue by Application (2017-2028)
6.3 North America Hepatitis B Vaccination Market Size by Country
6.3.1 North America Hepatitis B Vaccination Sales by Country (2017-2028)
6.3.2 North America Hepatitis B Vaccination Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis B Vaccination Market Size by Type
7.1.1 Europe Hepatitis B Vaccination Sales by Type (2017-2028)
7.1.2 Europe Hepatitis B Vaccination Revenue by Type (2017-2028)
7.2 Europe Hepatitis B Vaccination Market Size by Application
7.2.1 Europe Hepatitis B Vaccination Sales by Application (2017-2028)
7.2.2 Europe Hepatitis B Vaccination Revenue by Application (2017-2028)
7.3 Europe Hepatitis B Vaccination Market Size by Country
7.3.1 Europe Hepatitis B Vaccination Sales by Country (2017-2028)
7.3.2 Europe Hepatitis B Vaccination Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccination Market Size by Type
8.1.1 Asia Pacific Hepatitis B Vaccination Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis B Vaccination Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis B Vaccination Market Size by Application
8.2.1 Asia Pacific Hepatitis B Vaccination Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis B Vaccination Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis B Vaccination Market Size by Region
8.3.1 Asia Pacific Hepatitis B Vaccination Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis B Vaccination Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Hepatitis B Vaccination Market Size by Type
9.1.1 Latin America Hepatitis B Vaccination Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis B Vaccination Revenue by Type (2017-2028)
9.2 Latin America Hepatitis B Vaccination Market Size by Application
9.2.1 Latin America Hepatitis B Vaccination Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis B Vaccination Revenue by Application (2017-2028)
9.3 Latin America Hepatitis B Vaccination Market Size by Country
9.3.1 Latin America Hepatitis B Vaccination Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis B Vaccination Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Vaccination Market Size by Type
10.1.1 Middle East and Africa Hepatitis B Vaccination Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis B Vaccination Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis B Vaccination Market Size by Application
10.2.1 Middle East and Africa Hepatitis B Vaccination Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis B Vaccination Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis B Vaccination Market Size by Country
10.3.1 Middle East and Africa Hepatitis B Vaccination Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis B Vaccination Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 NCPC
11.2.1 NCPC Corporation Information
11.2.2 NCPC Overview
11.2.3 NCPC Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 NCPC Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NCPC Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Bio Kangtai
11.4.1 Bio Kangtai Corporation Information
11.4.2 Bio Kangtai Overview
11.4.3 Bio Kangtai Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bio Kangtai Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio Kangtai Recent Developments
11.5 Dynavax
11.5.1 Dynavax Corporation Information
11.5.2 Dynavax Overview
11.5.3 Dynavax Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dynavax Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dynavax Recent Developments
11.6 Hissen
11.6.1 Hissen Corporation Information
11.6.2 Hissen Overview
11.6.3 Hissen Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hissen Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hissen Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 KM Biologics Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 KM Biologics Recent Developments
11.8 LG Life Sciences
11.8.1 LG Life Sciences Corporation Information
11.8.2 LG Life Sciences Overview
11.8.3 LG Life Sciences Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 LG Life Sciences Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 LG Life Sciences Recent Developments
11.9 Serum Institute
11.9.1 Serum Institute Corporation Information
11.9.2 Serum Institute Overview
11.9.3 Serum Institute Hepatitis B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Serum Institute Hepatitis B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Serum Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis B Vaccination Industry Chain Analysis
12.2 Hepatitis B Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis B Vaccination Production Mode & Process
12.4 Hepatitis B Vaccination Sales and Marketing
12.4.1 Hepatitis B Vaccination Sales Channels
12.4.2 Hepatitis B Vaccination Distributors
12.5 Hepatitis B Vaccination Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis B Vaccination Industry Trends
13.2 Hepatitis B Vaccination Market Drivers
13.3 Hepatitis B Vaccination Market Challenges
13.4 Hepatitis B Vaccination Market Restraints
14 Key Findings in The Global Hepatitis B Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(hepatitis)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る